134 related articles for article (PubMed ID: 11090705)
1. Effects of macrophage colony-stimulating factor and interleukin-2 administration on NK1.1(+) cells in mice.
Misawa E; Sakurai T; Yamada M; Hayasawa H; Motoyoshi K
Int J Immunopharmacol; 2000 Nov; 22(11):967-77. PubMed ID: 11090705
[TBL] [Abstract][Full Text] [Related]
2. Booster effect of interleukin-2 on natural killer 1.1+ cells stimulated by administration of macrophage colony-stimulating factor in mice.
Misawa E; Sakurai T; Yamada M; Hayasawa H; Motoyoshi K
J Immunother; 2003; 26(1):21-30. PubMed ID: 12514426
[TBL] [Abstract][Full Text] [Related]
3. Effects of macrophage-colony-stimulating factor on cyclophosphamide-injected mouse NK1.1+ cell activity.
Sakurai T; Misawa E; Yamada M; Hayasawa H; Motoyoshi K
Cancer Immunol Immunother; 2000 May; 49(2):94-100. PubMed ID: 10823419
[TBL] [Abstract][Full Text] [Related]
4. Administration of macrophage colony-stimulating factor mobilized both CD11b+CD11c+ cells and NK1.1+ cells into peripheral blood.
Misawa E; Sakurai T; Yamada M; Tamura Y; Motoyoshi K
Int Immunopharmacol; 2004 Jun; 4(6):791-803. PubMed ID: 15135320
[TBL] [Abstract][Full Text] [Related]
5. Effect of coadministration of M-CSF and IFN-alpha on NK1.1+ cells in mice.
Sakurai T; Misawa E; Tanaka-Douzono M; Hagesita H; Nomaguchi K; Tetsuya K; Suzu S; Yamada M; Hayasawa H; Motoyoshi K
J Interferon Cytokine Res; 2002 Jun; 22(6):701-8. PubMed ID: 12162882
[TBL] [Abstract][Full Text] [Related]
6. Comparative study and effects of macrophage colony-stimulating factor (M-CSF) administration on NK1.1+ cells in mouse spleen and bone marrow.
Sakurai T; Misawa E; Yamada M; Hayasawa H; Motoyoshi K
Immunopharmacol Immunotoxicol; 2002 Nov; 24(4):547-66. PubMed ID: 12510790
[TBL] [Abstract][Full Text] [Related]
7. Activation of mouse liver natural killer cells and NK1.1(+) T cells by bacterial superantigen-primed Kupffer cells.
Dobashi H; Seki S; Habu Y; Ohkawa T; Takeshita S; Hiraide H; Sekine I
Hepatology; 1999 Aug; 30(2):430-6. PubMed ID: 10421651
[TBL] [Abstract][Full Text] [Related]
8. Effect of macrophage colony-stimulating factor on mouse NK 1.1+ cell activity in vivo.
Sakurai T; Wakimoto N; Yamada M; Shimamura S; Motoyoshi K
Int J Immunopharmacol; 1998 Aug; 20(8):401-13. PubMed ID: 9778101
[TBL] [Abstract][Full Text] [Related]
9. A critical role for IL-18 in the proliferation and activation of NK1.1+ CD3- cells.
Tomura M; Zhou XY; Maruo S; Ahn HJ; Hamaoka T; Okamura H; Nakanishi K; Tanimoto T; Kurimoto M; Fujiwara H
J Immunol; 1998 May; 160(10):4738-46. PubMed ID: 9590219
[TBL] [Abstract][Full Text] [Related]
10. Natural killer cell proliferation induced by anti-NK1.1 and IL-2.
Reichlin A; Yokoyama WM
Immunol Cell Biol; 1998 Apr; 76(2):143-52. PubMed ID: 9619484
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-18 and the costimulatory molecule B7-1 have a synergistic anti-tumor effect on murine melanoma; implication of combined immunotherapy for poorly immunogenic malignancy.
Cho D; Kim TG; Lee W; Hwang YI; Cho HI; Han H; Kwon O; Kim D; Park H; Houh D
J Invest Dermatol; 2000 May; 114(5):928-34. PubMed ID: 10771473
[TBL] [Abstract][Full Text] [Related]
12. Interferon gamma production by natural killer (NK) cells and NK1.1+ T cells upon NKR-P1 cross-linking.
Arase H; Arase N; Saito T
J Exp Med; 1996 May; 183(5):2391-6. PubMed ID: 8642351
[TBL] [Abstract][Full Text] [Related]
13. Role of NK1.1+ cells in experimental listeriosis. NK1+ cells are early IFN-gamma producers but impair resistance to Listeria monocytogenes infection.
Teixeira HC; Kaufmann SH
J Immunol; 1994 Feb; 152(4):1873-82. PubMed ID: 8120395
[TBL] [Abstract][Full Text] [Related]
14. Interleukin 2-induced proliferation of murine natural killer cells in vivo.
Biron CA; Young HA; Kasaian MT
J Exp Med; 1990 Jan; 171(1):173-88. PubMed ID: 1688606
[TBL] [Abstract][Full Text] [Related]
15. Protective effect of NK1.1(+) T cells as well as NK cells against intraperitoneal tumors in mice.
Kawamura T; Seki S; Takeda K; Narita J; Ebe Y; Naito M; Hiraide H; Abo T
Cell Immunol; 1999 May; 193(2):219-25. PubMed ID: 10222065
[TBL] [Abstract][Full Text] [Related]
16. Genetic control of natural killing and in vivo tumor elimination by the Chok locus.
Idris AH; Iizuka K; Smith HR; Scalzo AA; Yokoyama WM
J Exp Med; 1998 Dec; 188(12):2243-56. PubMed ID: 9858511
[TBL] [Abstract][Full Text] [Related]
17. Cytotoxic NK1.1 Ag+ alpha beta T cells with intermediate TCR induced in the liver of mice by IL-12.
Hashimoto W; Takeda K; Anzai R; Ogasawara K; Sakihara H; Sugiura K; Seki S; Kumagai K
J Immunol; 1995 May; 154(9):4333-40. PubMed ID: 7722291
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the phenotype and function of CD8(+), alpha / beta(+) NKT cells from tumor-bearing mice that show a natural killer cell activity and lyse multiple tumor targets.
Stremmel C; Exley M; Balk S; Hohenberger W; Kuchroo VK
Eur J Immunol; 2001 Sep; 31(9):2818-28. PubMed ID: 11536181
[TBL] [Abstract][Full Text] [Related]
19. Antitumor protection from the murine T-cell leukemia/lymphoma EL4 by the continuous subcutaneous coadministration of recombinant macrophage-colony stimulating factor and interleukin-2.
Vallera DA; Taylor PA; Aukerman SL; Blazar BR
Cancer Res; 1993 Sep; 53(18):4273-80. PubMed ID: 8364923
[TBL] [Abstract][Full Text] [Related]
20. IL-2-dependent generation of natural killer cells from bone marrow: role of MAC-1-, NK1-1- precursors.
Migliorati G; Moraca R; Nicoletti I; Riccardi C
Cell Immunol; 1992 May; 141(2):323-31. PubMed ID: 1533568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
